CIML, Canceropôle PACA
A therapeutic revolution is happening.
Cancéropôle PACA joins forces with Marseille-Immunopôle to the fight against cancer, through the structuration of ground-breaking platforms and the support of ambitious and strategic academic and translational research programs in the field of anti-tumoral immunotherapy.
A therapeutic revolution is happening.#research
Our study models help to identify new potential therapeutic targets in preclinical models of personalized medicine.
AMU, IPC, CRCM
Diagnostic in immuno-oncology is an innovative field combining the latest discoveries in immunology and new imaging technologies, such as digital pathology.
Marseille Immunopôle (Marseille Immunology Center) has the potential to provide precious help to open new diagnostic and therapeutic pathways and to provide our patients with even more options.
Immunotherapy is expanding to other cancers types: kidney cancer, bladder cancer, hepatocellular carcinoma, Hodgkin’s lymphoma, non-Hodgkin’s lymphoma… but we are still only at the beginning of the story!